SMARCA4 and Treacher-Collins syndrome: These results provide important information about the emerging role of SMARCA4 in sinonasal cancers and particularly suggest that TCS is on a spectrum with SMARCA4-deficient sinonasal carcinomas and could benefit from similar novel targeted therapies [95].